Publications

The BP - Multi-user Licence

Flexible annual multi-user licence (MUL) options to the BP Online, which includes access to all the monographs of the European Pharmacopoeia (Ph.Eur.) and in-year updates, are available to suit every need.  

From licences that allow unlimited users within one country to share access (within licence restrictions), to global enterprise and academic licences for wider availability. 

Standard MUL – provides unlimited users within one country, with access limited by the number of concurrent logins, i.e. logged in at the same time. Unlike seat-based licences, BP concurrent licences let unlimited users share access within the same country. 

Concurrency Limit BP Online BP Archive* BAN Online*
5 concurrent users  £2,520  £840  £400 
10 concurrent users  £4,463  £1,487  £750 
25 concurrent users  £6,374  £2,124  £1,500 
50 concurrent users  £10,763  £3,587  £2,748 
100 concurrent users  £14,763  £5,376  £4,500 
100+ concurrent users  Price on request

*BP Archive and BAN Online are optional Bolt-on products

Global enterprise MUL – provides global access for unlimited users at any time. Pricing and access details are available on request. 

Academic unlimited MUL – special academic rates are available for universities and teaching institutions. Pricing and access details are available on request. 

Please note: Licences with the Archive start on 1 August to align with the release schedule. Licences without the Archive start on 1 January to align with the legally effective period. Pro-rata pricing is available for new licence holders. 

If you need help choosing the right licence for your organisation, contact our customer services team who can offer tailored advice and support.

You can use our live webchat service, email us at pharmahealth@tso.co.uk or call us on +44 (0) 333 0917 023 and a member of our dedicated team will provide you with an accurate quotation. Please include or have to hand your requirements, including details of the locations that will require access and the number of potential users at each location and we will do the rest.​​​​

Our sales team are available Monday to Friday: 8:00 to 18:00 GMT

 Why choose multi-user licence?

Optimised Access for Your Team

Our MULs provide a set number of licensed users access to the BP Online whenever they need it. Whether your organisation operates nationally or globally, our flexible licences scale to match your needs. 

Flexible licensing models 

Choose the licence that fits your organisation’s needs: 

  • Standard MUL – A limited number of concurrent users within one country 
  • Global enterprise MUL – Unlimited concurrent users across multiple countries 
  • Academic unlimited MUL – Unlimited access for eligible educational institutions 

Cost-effective shared access 

The BP offers flexible online licences to suit your organisation. BP concurrent licences let unlimited users share access within the same country. 

Under the MUL model, access is shared: when the maximum number of licensed users are logged in at the same time, additional users must wait until an active session ends, either when a user logs off or is automatically logged out after a period of inactivity. 

Seamless access management 

Access is granted through one of the following methods: 

Inviting users - one or more licence managers are appointed within your organisation and will be granted permission to invite selected users to register and link to your licence. 

Domain recognition - users can register online and instantly gain access to your subscription if their email domain matches that of your organisation. 

Third-party access management services, including Open Athens and Shibboleth for academic licences. 

Trusted by organisations worldwide 

From pharmaceutical companies and regulatory agencies to universities and hospitals, many organisations rely on the British Pharmacopoeia’s multi-user licences for their daily operations.